- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03526133
Validation of Sleep Apnea Diagnosis Device
September 27, 2019 updated by: University of Sao Paulo General Hospital
Validation of a Wireless Wearable Sensor Using Mobile Technology and Cloud Computing for the Diagnosis of Sleep Apnea
Obstructive sleep apnea (OSA) is common and largely underdiagnosed disease.
The standard method for the diagnosis of OSA is a complete night polysomnography (PSG).
Simple methods for OSA diagnosis are necessary.
The overnight oximetry with the oxygen desaturation index (ODI) has been largely investigated as a diagnostic test for OSA but its accuracy remains undefined.
The aim of our study is to evaluate if an wireless polygraph (Oxistar) is accurate to diagnosis OSA in patients referred to a Sleep Lab.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Consecutive patients referred to the sleep laboratory with suspected diagnosis of OSA underwent in-laboratory polysomnography (PSG) and simultaneously wireless polygraph.
The PSG oximeter and the wireless polygraph were worn on different fingers of the same hand.
All sleep studies were reviewed by one blind investigator according the 2017 American Academy of Sleep Medicine recommendations.
The number of desaturations from wireless polygraph at the 3 predefined threshold levels (of ODI-2%, ODI-3%, or ODI-4%) was derived automatically using proprietary algorithm.
Moderate to severe OSA was defined as AHI ≥ 15 events/h.
The diagnostic accuracy of ODI-2%, 3%, and 4% for the diagnosis of moderate-severe OSA were calculated for cut-off values from 1 to 20 desaturation events/h.
The sleep actimetry was compared with the sleep stages from PSG, most of the statistical metrics applied for diagnosis were used to evaluate the applicability of this proposed method.
Finally, the snoring events computed by the smartphone application were compared with the events heard by a specialist and the statistical comparison metrics were evaluated.
Study Type
Observational
Enrollment (Actual)
300
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Sao Paulo, Brazil, 05403-900
- Incor - Heart Institute, Sleep Laboratory
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Consecutive patients referred to a university-based tertiary sleep referral centre.
Description
Inclusion Criteria:
- referred by medical staff for an overnight assessment for suspected sleep apnea
Exclusion Criteria:
- polysomnography for the CPAP titration
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Sensitivity
Time Frame: Night during the polysomnography exam
|
Sensitivity of Oxistar device to detect apnea events compared to gold-standard polysomnography
|
Night during the polysomnography exam
|
|
Specificity
Time Frame: Night during the polysomnography exam
|
Specificity of Oxistar device to detect apnea events compared to gold-standard polysomnography
|
Night during the polysomnography exam
|
|
Area under the curve (AUC)
Time Frame: Night during the polysomnography exam
|
AUC from ROC curves reflects the accuracy of Oxistar device to detect apnea events compared to gold-standard polysomnography
|
Night during the polysomnography exam
|
|
Bland-Altman Graph
Time Frame: Night during the polysomnography exam
|
The Bland-Altman graph evaluates the "agreement" between the gold-standard polysomnography and Oxistar device
|
Night during the polysomnography exam
|
|
Interclass Correlation Coefficient (ICC)
Time Frame: Night during the polysomnography exam
|
ICC measures the reliability of measurements or ratings between the gold-standard polysomnography and Oxistar device
|
Night during the polysomnography exam
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Sleep Actigraphy
Time Frame: Night during the polysomnography exam
|
Actigraphy is the continuous measurement of activity or movement with the use of a small device called an actigraph.
Periods of movement suggest wakefulness while those of relative stillness would likely correspond to sleep or quiescence.
The Oxistar has a embeded actigraph whose data will be compared with the sleep stage scoring from polysomnography (PSG), the gold standard for sleep assessment.
Epoch-by-epoch (30 seconds) agreement between the actigraph and PSG will be assessed by calculating sensitivity, specificity, accuracy, area under the curve (AUC), Bland-Altman graph and interclass correlation coefficient (ICC)
|
Night during the polysomnography exam
|
|
Number of snoring events per hour of register (snoring/h)
Time Frame: Night during the polysomnography exam
|
Snoring is one of the signs suggestive of obstructive sleep apnea and has recently been considered as having great diagnostic potential.
The smartphone application (app) through microphone performs the recording and the characteristics extraction of the patient's audio during sleep (register time).
A multilayer perceptron (MPL) neural network classifies the event as snoring or non-snoring.
Lastly, the amount of snoring occured is accounted and divided by the register time leading to the number of snoring/h.
The agreement between snoring/h measured by the app and the heard by a specialist will be assessed by calculating sensitivity, specificity, accuracy and area under the curve (AUC).
|
Night during the polysomnography exam
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Geraldo Lorenzi-Filho, MD, PhD, Associate Professor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 7, 2017
Primary Completion (Actual)
December 7, 2018
Study Completion (Actual)
February 7, 2019
Study Registration Dates
First Submitted
April 12, 2018
First Submitted That Met QC Criteria
May 3, 2018
First Posted (Actual)
May 16, 2018
Study Record Updates
Last Update Posted (Actual)
September 30, 2019
Last Update Submitted That Met QC Criteria
September 27, 2019
Last Verified
July 1, 2018
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 70485317.0.0000.0068
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.